Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Maestro Surgical Robotics System by Moon Surgical, Now CE Marked


PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / April 12, 2023 / Moon Surgical, a French-American pioneer in collaborative robotics, announced today that its Maestro System is now CE Marked under the Medical Device Regulation (EU) 2017/745.

 

"This new milestone is a testament to our team's hard work and dedication, and attests to the effective ramp-up of our manufacturing and quality operations," said Anne Osdoit, CEO of Moon Surgical, and a Partner in Sofinnova Partners' medtech accelerator, MD Start. "With the Maestro System, we aim to empower surgeons to perform laparoscopy with greater ease, precision, and control, improving patient outcomes and enhancing the overall surgical experience."

 

Ein Bild, das Logo enthält.

Automatisch generierte Beschreibung

 

Thus far, fifty patients in Europe have benefited from a Maestro-assisted surgery in a clinical trial led by Pr. Guy-Bernard Cadière in Brussels, Belgium.

 

Globally, over 18 million patients undergo soft tissue procedures annually without the advantages of robotic surgical platforms. With the Maestro System, Moon Surgical is developing a new category of surgery that enhances traditional laparoscopy. Its state-of-the-art surgical assistance platform is specifically designed to augment the precision and control of laparoscopic surgery, supporting high-volume surgeons performing procedures such as cholecystectomy and hernia repairs and more complex multi-quadrant procedures.

 

Moon Surgical was founded by Professor Brice Gayet, a world-renowned laparoscopic surgeon, and incubated by Sofinnova Partners MD Start in 2020; it has moved swiftly since. The company raised $31m in May 2022, and, shortly after, announced the completion of a First-in-Human study and FDA clearance for an initial version of its Maestro system, in December of 2022.

 

About Moon Surgical

 

Moon Surgical, based in Paris, France, and San Francisco, California, believes the future of the operating room lies in the hands of the empowered surgeon.

 

By equipping surgeons with complete control, renewed confidence, and adaptable technology to any situation, Moon Surgical strives to improve efficiency in operating rooms and provide better surgical care for patients. The minimalistic, co-manipulation Maestro System uses tomorrow's technology to deliver these vital skills to surgeons, today.

 

www.moonsurgical.com

 

Contact

Investors and Media: [email protected]

(650) 264-8165

 

Moon Surgical® and Maestro® are registered trademarks of Moon Surgical, SAS

 

SOURCE: Moon Surgical

 

Sas Ab Aktie

0,003 €
-7,41 %
Einen Verlust von -7,41 % verzeichnet heute die Sas Ab Aktie.

Like: 0
Teilen

Kommentare